March 3 to 7
MONTEVIDEO, URGUAY
LATAM Master Course 2026
Hematopoietic Stem Cell Transplantation and CAR-T Cell TherapyS
The LATAM Mastercourse 2026, organized by the Princess Máxima Center and the Fundación Pérez Scremini, will once again bring together international and regional leaders in pediatric oncology in Montevideo.
In its third edition, the course will focus on Hematopoietic Stem Cell Transplantation and CAR-T Cell Therapy, two of the most innovative strategies in the treatment of children, adolescents, and young adults with cancer.
Over five intensive days, experts from world-renowned centers such as the Princess Máxima Center for Pediatric Oncology (The Netherlands), San Gerardo Hospital dei Tintoti (Italy), Memorial Sloan Kettering Cancer Center and the University of Miami (United States), Hospital Sant Joan de Déu (Barcelona, Spain), Hospital Austral (Argentina), and GRAACC – Grupo de Apoio ao Adolescente e à Criança com Câncer (Brazil), together with leading Latin American specialists, will share their knowledge and experiences through a program tailored to the realities of the region.
With limited availability, this event offers a unique opportunity for cutting-edge education, scientific exchange, and international collaboration in pediatric oncology.
Participants will explore key aspects of allogeneic stem cell transplantation (HSCT) and CAR-T cell therapy, including:
-
Indications and timing of HSCT for ALL, AML, lymphomas, bone marrow failure, and immunodeficiencies.
-
Conditioning regimens: donor sources (matched sibling, unrelated, haploidentical, cord blood) and intensity strategies.
-
Supportive care: central lines, mucositis, antimicrobial prophylaxis, nutrition, and pain management.
-
Acute and chronic complications: graft-versus-host disease (GvHD), sinusoidal obstruction syndrome (VOD/SOS), and infection management.
-
Survivorship and late effects: endocrine, cardiopulmonary, and neurocognitive outcomes, fertility, and secondary tumors.
-
Psychosocial and family-centered care: schooling, coping, and transition into adult care.
-
CAR-T therapy: patient eligibility, manufacturing process, infusion monitoring, CRS and ICANS management, ICU support, and long-term follow-up.
-
Future directions and access in Latin America, including a regional panel on how to make CAR-T therapy available in the region.
DAY 1 , 2 AND 3
HOMATOPOIETIC STEM CELL TRANSPLANTATION
DAY4 AND 5
CAR T CELL THERAPY
DIRECTORS
LENNEKE SCHRIER
Princess Máxima Center
Países Bajos
GERTJAN KASPERS
Princess Máxima Center
Países Bajos
GUILLERMO CHANTADA
Fundación Pérez Scremini
Uruguay
LUIS NEY CASTILLO
Fundación Pérez Scremini
Uruguay
Speakers
International experts share their expertise
Caroline Lindemans
Princess Máxima Center for Pediatric Oncology (Países Bajos)
Gertjan Kaspers
Princess Máxima Center for Pediatric Oncology (Países Bajos)
María Cancio
Memorial Sloan Kettering Cancer Center
(Estados Unidos)
Anna Alonso Saladriguez
Hospital San Juan de Dios
(Barcelona, España)
Emmelien Buddingh
Princess Máxima Center for Pediatric Oncology (Países Bajos)
Lenneke Schrier
Princess Máxima Center for Pediatric Oncology (Países Bajos)
Silvio Torres
Hospital Austral
(Argentina)
Marc Bierings
Princess Máxima Center for Pediatric Oncology (Países Bajos)
Marta Verna
San Gerardo Hospital dei Tintoti
(Italia)
Julio Barredo
University of Miami
(Estados Unidos)
All educational sessions are given by international experts in the field. All participants receive a certificate of attendance after completing a module and an overall certificate after completing all modules
DATE
Four ½ day meeting scheduled to be in March 3 - 7, 2026.
venue
Auditorium Fundación Pérez Scremini, Montevideo, Uruguay
LANGUAGE
English with no simultaneous translation
FORMAT
Full day in-person meeting with up to 50 attendees.
MODALITY
“Flip classroom”
format providing the necessary reading in advance for attendees.
